BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30206265)

  • 1. Inhibition of Wnt/β-catenin signaling suppresses myofibroblast differentiation of lung resident mesenchymal stem cells and pulmonary fibrosis.
    Cao H; Wang C; Chen X; Hou J; Xiang Z; Shen Y; Han X
    Sci Rep; 2018 Sep; 8(1):13644. PubMed ID: 30206265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3-mediated m6A RNA methylation induces the differentiation of lung resident mesenchymal stem cells into myofibroblasts via the miR-21/PTEN pathway.
    Lu Y; Liu Z; Zhang Y; Wu X; Bian W; Shan S; Yang D; Ren T
    Respir Res; 2023 Nov; 24(1):300. PubMed ID: 38017523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
    Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
    Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway.
    Yin JZ; Li ZQ; Zhang XD; Wan ZJ; Qin HR; Yao LH; Li BL; Gao F; Yang YY
    Eur J Pharmacol; 2024 Feb; 964():176293. PubMed ID: 38158113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis.
    Zhao X; Wu J; Yuan R; Li Y; Yang Q; Wu B; Zhai X; Wang J; Magalon J; Sabatier F; Daumas A; Zhu WM; Zhu N
    Sci Rep; 2023 Aug; 13(1):13183. PubMed ID: 37580529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis.
    Escarrer-Garau G; Martín-Medina A; Truyols-Vives J; Gómez-Bellvert C; Elowsson L; Westergren-Thorsson G; Molina-Molina M; Mercader-Barceló J; Sala-Llinàs E
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt pathway in pulmonary fibrosis in the bleomycin mouse model.
    Liu L; Carron B; Yee HT; Yie TA; Hajjou M; Rom W
    J Environ Pathol Toxicol Oncol; 2009; 28(2):99-108. PubMed ID: 19817697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cells modulate the Wnt pathway in the bleomycin-induced model of idiopathic pulmonary fibrosis.
    Bayati P; Taherian M; Soleimani M; Farajifard H; Mojtabavi N
    Stem Cell Res Ther; 2023 Nov; 14(1):343. PubMed ID: 38017561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.
    Marriott S; Baskir RS; Gaskill C; Menon S; Carrier EJ; Williams J; Talati M; Helm K; Alford CE; Kropski JA; Loyd J; Wheeler L; Johnson J; Austin E; Nozik-Grayck E; Meyrick B; West JD; Klemm DJ; Majka SM
    Am J Physiol Cell Physiol; 2014 Oct; 307(8):C684-98. PubMed ID: 25122876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation.
    Teo JL; Ma H; Nguyen C; Lam C; Kahn M
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12171-6. PubMed ID: 16093313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Drug Screening Identifies a Potent Wnt Inhibitor that Promotes Airway Basal Stem Cell Homeostasis.
    Aros CJ; Paul MK; Pantoja CJ; Bisht B; Meneses LK; Vijayaraj P; Sandlin JM; France B; Tse JA; Chen MW; Shia DW; Rickabaugh TM; Damoiseaux R; Gomperts BN
    Cell Rep; 2020 Feb; 30(7):2055-2064.e5. PubMed ID: 32075752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review.
    Srour N; Thébaud B
    Stem Cells Transl Med; 2015 Dec; 4(12):1500-10. PubMed ID: 26494779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myofibroblast-specific inhibition of the Rho kinase-MRTF-SRF pathway using nanotechnology for the prevention of pulmonary fibrosis.
    Knipe RS; Nurunnabi M; Probst CK; Spinney JJ; Abe E; Bose RJC; Ha K; Logue A; Nguyen T; Servis R; Drummond M; Haring A; Brazee PL; Medoff BD; McCarthy JR
    Am J Physiol Lung Cell Mol Physiol; 2023 Feb; 324(2):L190-L198. PubMed ID: 36625494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation.
    Jun D; Garat C; West J; Thorn N; Chow K; Cleaver T; Sullivan T; Torchia EC; Childs C; Shade T; Tadjali M; Lara A; Nozik-Grayck E; Malkoski S; Sorrentino B; Meyrick B; Klemm D; Rojas M; Wagner DH; Majka SM
    Stem Cells; 2011 Apr; 29(4):725-35. PubMed ID: 21312316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genesis of the myofibroblast in lung injury and fibrosis.
    Phan SH
    Proc Am Thorac Soc; 2012 Jul; 9(3):148-52. PubMed ID: 22802289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icariside II modulates pulmonary fibrosis via PI3K/Akt/β-catenin pathway inhibition of M2 macrophage program.
    Deng L; Ouyang B; Tang W; Wang N; Yang F; Shi H; Zhang Z; Yu H; Chen M; Wei Y; Dong J
    Phytomedicine; 2024 May; 130():155687. PubMed ID: 38759312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resident mesenchymal vascular progenitors modulate adaptive angiogenesis and pulmonary remodeling via regulation of canonical Wnt signaling.
    Summers ME; Richmond BW; Menon S; Sheridan RM; Kropski JA; Majka SA; Taketo MM; Bastarache JA; West JD; De Langhe S; Geraghty P; Klemm DJ; Chu HW; Friedman RS; Tao YK; Foronjy RF; Majka SM
    FASEB J; 2020 Aug; 34(8):10267-10285. PubMed ID: 32533805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis.
    Lee JH; Lee CM; Lee JH; Kim MO; Park JW; Kamle S; Akosman B; Herzog EL; Peng XY; Elias JA; Lee CG
    Am J Respir Cell Mol Biol; 2022 Sep; 67(3):309-319. PubMed ID: 35679109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis.
    Ligresti G; Raslan AA; Hong J; Caporarello N; Confalonieri M; Huang SK
    Gene; 2023 Apr; 859():147142. PubMed ID: 36603696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.